Literature DB >> 26138102

Ethics and germline gene editing.

Jeremy Sugarman1.   

Abstract

Mesh：

Year:  2015        PMID： 26138102      PMCID： PMC4552475          DOI： 10.15252/embr.201540879

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  9 in total

1.  Commentary: maintaining the somatic/germ-line distinction: some ethical drawbacks.

Authors:  R Moseley
Journal:  J Med Philos       Date:  1991-12

2.  The oversight and practice of oocyte donation in the United States, United Kingdom and Canada.

Authors:  Aaron D Levine
Journal:  HEC Forum       Date:  2011-03

3.  Ethical issues in manipulating the human germ line.

Authors:  M Lappé
Journal:  J Med Philos       Date:  1991-12

Review 4.  Germ-line gene modification and disease prevention: some medical and ethical perspectives.

Authors:  N A Wivel; L Walters
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

Review 5.  Genetic modification of preimplantation embryos: toward adequate human research policies.

Authors:  Rebecca Dresser
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

6.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

7.  Biotechnology. A prudent path forward for genomic engineering and germline gene modification.

Authors:  David Baltimore; Paul Berg; Michael Botchan; Dana Carroll; R Alta Charo; George Church; Jacob E Corn; George Q Daley; Jennifer A Doudna; Marsha Fenner; Henry T Greely; Martin Jinek; G Steven Martin; Edward Penhoet; Jennifer Puck; Samuel H Sternberg; Jonathan S Weissman; Keith R Yamamoto
Journal:  Science       Date:  2015-03-19       Impact factor: 47.728

8.  CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.

Authors:  Puping Liang; Yanwen Xu; Xiya Zhang; Chenhui Ding; Rui Huang; Zhen Zhang; Jie Lv; Xiaowei Xie; Yuxi Chen; Yujing Li; Ying Sun; Yaofu Bai; Zhou Songyang; Wenbin Ma; Canquan Zhou; Junjiu Huang
Journal:  Protein Cell       Date:  2015-04-18       Impact factor: 14.870

Review 9.  International regulatory landscape and integration of corrective genome editing into in vitro fertilization.

Authors:  Motoko Araki; Tetsuya Ishii
Journal:  Reprod Biol Endocrinol       Date:  2014-11-24       Impact factor: 5.211
  9 in total
  10 in total

1.  No time to waste--the ethical challenges created by CRISPR: CRISPR/Cas, being an efficient, simple, and cheap technology to edit the genome of any organism, raises many ethical and regulatory issues beyond the use to manipulate human germ line cells.

Authors:  Arthur L Caplan; Brendan Parent; Michael Shen; Carolyn Plunkett
Journal:  EMBO Rep       Date:  2015-10-08       Impact factor: 8.807

2.  Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE.

Authors:  Guido De Wert; Björn Heindryckx; Guido Pennings; Angus Clarke; Ursula Eichenlaub-Ritter; Carla G van El; Francesca Forzano; Mariëtte Goddijn; Heidi C Howard; Dragica Radojkovic; Emmanuelle Rial-Sebbag; Wybo Dondorp; Basil C Tarlatzis; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2018-01-12       Impact factor: 4.246

3.  Elucidation of CRISPR-Cas9 application in novel cellular immunotherapy.

Authors:  Sameer Quazi
Journal:  Mol Biol Rep       Date:  2022-02-05       Impact factor: 2.742

Review 4.  Women who suffer from schizophrenia: Critical issues.

Authors:  Mary V Seeman
Journal:  World J Psychiatry       Date:  2018-11-09

5.  Trust in Science: CRISPR-Cas9 and the Ban on Human Germline Editing.

Authors:  Stephan Guttinger
Journal:  Sci Eng Ethics       Date:  2017-06-26       Impact factor: 3.525

6.  CRISPR in the North American popular press.

Authors:  Alessandro Marcon; Zubin Master; Vardit Ravitsky; Timothy Caulfield
Journal:  Genet Med       Date:  2019-04-12       Impact factor: 8.822

Review 7.  A review of COVID-19: Treatment strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease.

Authors:  Muhammad Farhat Ullah; Yasir Ali; Muhammad Ramzan Khan; Inam Ullah Khan; Bing Yan; M Ijaz Khan; M Y Malik
Journal:  Saudi J Biol Sci       Date:  2021-10-13       Impact factor: 4.219

Review 8.  An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its Applications.

Authors:  Fatima Akram; Sania Sahreen; Farheen Aamir; Ikram Ul Haq; Kausar Malik; Memoona Imtiaz; Waqas Naseem; Narmeen Nasir; Hafiza Mariam Waheed
Journal:  Mol Biotechnol       Date:  2022-04-26       Impact factor: 2.860

9.  Responsible governance of human germline genome editing in China†.

Authors:  Yaojin Peng; Jianwei Lv; Lulu Ding; Xia Gong; Qi Zhou
Journal:  Biol Reprod       Date:  2022-07-25       Impact factor: 4.161

10.  Responsible innovation in human germline gene editing. Background document to the recommendations of ESHG and ESHRE.

Authors:  Guido de Wert; Björn Heindryckx; Guido Pennings; Angus Clarke; Ursula Eichenlaub-Ritter; Carla G van El; Francesca Forzano; Mariëtte Goddijn; Heidi C Howard; Dragica Radojkovic; Emmanuelle Rial-Sebbag; Wybo Dondorp; Basil C Tarlatzis; Martina C Cornel
Journal:  Hum Reprod Open       Date:  2018-01-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.